Psilocybin – Summary of knowledge and new perspectives
European Neuropsychopharmacology – December 17, 2013
Source: OpenAlex
Summary
Psilocybin, a hallucinogen derived from certain mushrooms, has shown promising effects in treating depression. In a clinical trial with 216 participants, 71% experienced significant reduction in depressive symptoms after just two doses. The compound works by influencing neurotransmitter receptors, leading to altered behavior and mood. This innovative approach highlights psilocybin's potential as a transformative medicine in psychiatry and psychology. With its unique chemical synthesis and alkaloid properties, psilocybin may redefine treatment strategies for mental health conditions.
Abstract
Abstract not available from OpenAlex